Each AI model was fed detailed scenario prompts spanning border conflicts, resource shortages, and existential threats to state survival. They were provided with an "escalation ladder," ...

How do you know anything is real? Some things you can see directly, like your fingers. Other things, like your chin, you need a mirror or a camera to see.

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer—has long captured the public imagination. Yet most arguments about it rest ...

BMS Group has announced a strategic partnership with Berns Brett India, signalling its expansion into the Indian market, with the local entity set to be rebranded BMS (India) Ltd pending regulatory ...

Course-based ideological and political education (CBIPE) serves as a vital pathway for fulfilling the fundamental mission of fostering virtue through education. Simulation-based experimental teaching, ...

Analysts had noted “unease” from investors regarding the state of the Phase III ADEPT-2 trial, with BMS at one point telling Leerink Partners that the reopening of enrollment would be a “significant ...

New research from UBC Okanagan mathematically demonstrates that the universe cannot be simulated. Using Gödel’s incompleteness theorem, scientists found that reality requires “non-algorithmic ...

Growing up in a small town in India, I witnessed firsthand the challenges of accessing basic medical information and care. Even a simple diagnostic test required travel to a distant, larger town.

Adam is a lifelong gamer who enjoys RPGs, action adventure games and a healthy helping of VR to boot. He has written for countless sites in the gaming medium, and you can find him playing the newest ...

While no one has figured out how to make money from generative artificial intelligence, that hasn’t stopped Google DeepMind from pushing the boundaries of what’s possible with a big pile of inference.

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain Capital-led financing as part of the Big Pharma’s ambitious cost-cutting drive.

Samit Hirawat, M.D., Executive Vice President, to step down from his role on August 1 and will depart BMS on November 1 PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today ...